January 13, 2010
Multiple Sclerosis: A Breakthrough Is on the Way
A number of improved treatments will be available soon, and Novartis’ Fingolimod could lead the way… What doctors can’t guarantee is that the drugs will suppress the illness without triggering infections. “We desperately need new drugs for MS,” says Dr. Mark Keegan, section chair of multiple sclerosis at the Mayo Clinic in Rochester, but […]
Tags: multiple scleroris, Novartis